MEDU-34. PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHILDREN WITH WNT-POSITIVE STANDARD RISK MEDULLOBLASTOMA

BACKGROUND: Molecular subclassification of medulloblastoma identifies Wnt-positive medulloblastoma (WPM) as a highly favorable subtype with event-free survival (EFS) exceeding 90% when treating patients following near total or complete resection with standard dose craniospinal irradiation and boost...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Cohen, Kenneth, Bandopadhayay, Pratiti, Chi, Susan, London, Wendy, Rodriguez, Fausto, Hawkins, Cynthia, Yang, Edward, Aguilera, Dolly, Castellino, Robert, MacDonald, Tobey, Stapleton, Stacie, Ashley, David
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Medulloblastoma
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477321/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.192
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars